Despite considerable efforts to improve the quality of end-of-life care in the United States, a new retrospective study led by American Cancer Society (ACS) researchers revealed that close to half of ...

This study was aimed at evaluating the safety and efficacy of the Tendvia system for intermediate-risk acute PE. This prospective, single-arm, multicenter study included symptomatic patients with ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at least as effective and costs only 50 cents a pill? They will if the ...

The Food and Drug Administration has approved a new pain medication that could take the place of opioids for those experiencing moderate to severe acute pain. The drug is Journavx, or the generic ...

In a letter addressed to Guterres, Danon outlined the rationale behind the decision, emphasizing "the acute national security risks posed by the widespread infiltration of UNRWA’s ranks by Hamas ...